GP stakes

Backed by family office capital at inception in 2001, Texas-based CAZ has become one of the largest allocators to GP stakes funds and directs over the past two decades.

Since its inception in 2018, Capital Constellation has deployed more than $2bn to minority investments in 19 emerging managers.

The firm had previously been expecting to hit Fund VI’s $13bn target by end-2025.

In this podcast, PEI Group editors discuss what GPs say they're focusing on amid the trade war-induced uncertainty, how the secondaries market stands to benefit, and how investors are reacting to the volatile environment.

Consolidation in the alternative asset management industry is creating opportunities for GP stake investors and their portfolios, argue DC Advisory’s Hal Ritch, Donato de Donato and Jacob Berman.

Despite recent headwinds, the GP stakes market is evolving – with value creation, liquidity pressures and direct investment strategies reshaping the outlook for both managers and investors.

The sheer volume of management company, fund and portfolio-level data involved in GP stakes investing means the asset class is ripe for an AI revolution.

As GP stakes portfolios age, funds are testing out new paths to liquidity in this particularly long-term corner of the PE industry.

GP stakes investors are increasingly differentiating themselves by bigging up their value creation capabilities. We explore what these minority owners can realistically bring to the table that GPs can’t do for themselves.

GP stakes investing is poised for further expansion, thanks to rising demand and better investor understanding, says Michael Rees, co-president of Blue Owl Capital.